A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides

Gallardo, Gilbert, Schlüter, Oliver M, Südhof, Thomas C·2008·Nature Neuroscience
DOI 10.1038/nn2058

Cited by (145)

Items 101–145 of 145

  1. Investigating the Interplay between Cardiovascular and Neurodegenerative Disease
    J. Cousineau, Aimee Maria Dawe, Melanie Alpaugh · 2024 · Biology
  2. Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study
    Ryota Sakurai, Frederico Pieruccini‐Faria, Benjamin F. Cornish, Julia Fraser, Malcolm A. Binns, Derek Beaton, Allison Ann Dilliott, Donna T. Kwan, Joel Ramirez, Brian Tan et al. · 2024 · Alzheimer s & Dementia
  3. Scavenging effect of Naoerkang (脑尔康) on amyloid beta-peptide deposition in the hippocampus in a rat model of Alzheimer’s disease
    Xi Li, Hai-Feng Yuan, Qian-kun Quan, Jian-Jun Wang, Ning-ning Wang, Ming Li · 2011 · Chinese Journal of Integrative Medicine
  4. Commonalities in the genetics of Alzheimer’s disease and Parkinson’s disease
    Edna Grünblatt · 2008 · Expert Review of Neurotherapeutics
  5. MultiTEP platform–based DNA vaccines for alpha-synucleinopathies: preclinical evaluation of immunogenicity and therapeutic potency
    Hayk Davtyan, Karen Zagorski, Irina Petrushina, Konstantin Kazarian, Natalie R.S. Goldberg, Janet Petrosyan, Mathew M. Blurton-Jones, Eliezer Masliah, David H. Cribbs, Michael G. Agadjanyan et al. · 2017 · Neurobiology of Aging
  6. Exploring the effect of APOE ε4 on biomarkers of neurodegeneration in Alzheimer’s disease
    Luisa Agnello, Caterina Maria Gambino, Anna Maria Ciaccio, Tommaso Piccoli, Valeria Blandino, Concetta Scazzone, Bruna Lo Sasso, Fabio Del Ben, Marcello Ciaccio · 2024 · Clinica Chimica Acta
  7. Advancements in a FRET Biosensor for Live-Cell Fluorescence-Lifetime High-Throughput Screening of Alpha-Synuclein
    Anthony R. Braun, Noah Nathan Kochen, Samantha L. Yuen, Elly E. Liao, Rǎzvan L. Cornea, David Dale Thomas, Jonathan N. Sachs · 2023 · ASN NEURO
  8. Proteomic Serum Profile of Fatigued Men Receiving Localized External Beam Radiation Therapy for Non-Metastatic Prostate Cancer
    Nada Lukkahatai, Sajni Patel, Marjan Guček, Chao‐Pin Hsiao, Leorey N. Saligan · 2013 · Journal of Pain and Symptom Management
  9. Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
    Lloyd, Grace M., Long, Brooke, Quintin, Stephan, Sorrentino, Zachary A., Gorion, Kimberly-Marie M., Bell, Brach M., Carrillo, Denise, Sullivan, Patrick, Borchelt, David, Giasson, Benoit I. · 2023 · Acta Neuropathologica Communications
  10. Curious Dichotomies of Apolipoprotein E Function in Alzheimer’s Disease and Cancer—One Explanatory Mechanism of Inverse Disease Associations?
    Perks, Claire M., Barker, Rachel M., Alhadrami, Mai, Alkahtani, Omar, Gill, Emily, Grishaw, Mary, Harland, Abigail J., Henley, Peter, Li, Haonan, O’Sullivan, Ellie et al. · 2025 · Genes
  11. Minimal Nucleation State of α-Synuclein Is Stabilized by Dynamic Threonine–Water Networks
    Tod D. Romo, Andrew K. Lewis, Anthony R. Braun, Alan M. Grossfield, Jonathan N. Sachs · 2017 · ACS Chemical Neuroscience
  12. Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein
    Jingfeng Liang, Rongzhen Li, Garry Wong, Xiaobing Huang · 2025 · Molecular Neurodegeneration
  13. Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein
    Seo‐Jun Kang, Soo‐Jeong Kim, Hye Rin Noh, Beom Jin Kim, Jae-Bong Kim, Uram Jin, Sun Ah Park, Sang Myun Park · 2022 · International Journal of Molecular Sciences
  14. Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer’s Disease and Its Tg2576 Mouse Model
    Alexandra Bluhm, Sarah Schrempel, Stephan Schilling, Stephan von Hörsten, Anja Schulze, Steffen Roßner, Maike Hartlage‐Rübsamen · 2022 · Biomolecules
  15. Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues
    Hayder Mutter Al-Kuraishy, Ghassan Mohammad Sulaiman, Hamdoon Abdelhamid Mohammed, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Amer Al Ali, Mohammed Haidar Abu-Alghayth · 2025 · Ageing Research Reviews
  16. Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson’s disease: A Preliminary Study
    Ashish Kumar Gupta, Komal Rani, Surabhi Swarnkar, Gaurav Khunger Kumar, Mohd Imran Khan, Ruchika Pokhriyal, Domada Ratna Kumar, Vinay Goyal, Manjari Tripathi, Rishab Gupta et al. · 2018 · Journal of Central Nervous System Disease
  17. Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
    Ashish Kumar Gupta, Ruchika Pokhriyal, Uddipan Das, Mohd Imran Khan, Domada Ratna Kumar, Rishab Gupta, Rakesh Kumar Chadda, Rashmi Ramachandran, Vinay Goyal, Manjari Tripathi et al. · 2019 · Neuropsychiatric Disease and Treatment
  18. Mapping the Interactive Effects of ApoE Gene Polymorphism on Caudate Functional Connectivity in Mild Cognitive Impairment Associated With Parkinson’s Disease
    Song’an Shang, Yu‐Chen Chen, Hongying Zhang, Weiqiang Dou, Long Qian, Xindao Yin, Jingtao Wu · 2020 · Frontiers in Neuroscience
  19. The effect of copy number on α-synuclein’s toxicity and its protective role in Bax-induced apoptosis, in yeast
    Damilare D. Akintade, Bhabatosh Chaudhuri · 2020 · Bioscience Reports · Retracted
  20. Lipoprotein lipase deficiency leads to α-synuclein aggregation and ubiquitin C-terminal hydrolase L1 reduction
    Hua Yang, Ting Zhou, Hui Wang, Tianyi Liu, K. Ueda, Rui Zhan, Lei Zhao, Y. Tong, X. Tian, T. Zhang et al. · 2015 · Neuroscience
  21. Endogenous mouse huntingtin is highly abundant in cranial nerve nuclei, co-aggregates to Abeta plaques and is induced in reactive astrocytes in a transgenic mouse model of Alzheimer’s disease
    Maike Hartlage‐Rübsamen, Veronika Ratz, Ulrike Zeitschel, Lukas Finzel, Lisa Machner, Janett Köppen, Anja Schulze, Hans‐Ulrich Demuth, Stephan von Hörsten, Corinna Höfling et al. · 2019 · Acta Neuropathologica Communications
  22. Detrimental Effects of Paraquat on Astrocytes-Regulating Synaptic Functions
    Zheng Li, Jing Zheng, Xiao-Feng Zhang · 2018 · Dose-Response
  23. Antioxidant modulation in restoring mitochondrial function in neurodegeneration
    Aslina Pahrudin Arrozi, Wan Zurinah Wan Ngah, Yasmin Anum Mohd Yusof, Hanafi Ahmad Damanhuri, Suzana Makpol · 2016 · International Journal of Neuroscience
  24. The genetic predictors of cognitive impairment in Parkinson's disease
    Konstantin A. Senkevich, Irina V. Miliukhina, С. Н. Пчелина · 2018 · S S Korsakov Journal of Neurology and Psychiatry
  25. Association between Apolipoprotein E Polymorphisms and Epilepsy in Children
    Monika Kukuruzović · 2021 · Acta Clinica Croatica
  26. The genetics of dementia with Lewy bodies
    Magdalena Ioana Tolea, James E. Galvin · 2018 · Handbook of clinical neurology
  27. Effect of APOE genotype on gray matter density in patients with Parkinson's disease
    Seok Jong Chung, Ji Eun Lee, Jin Yong Hong, Soohwan Lim, Myong Hwan Kim, Young H. Sohn, Phil Hyu Lee · 2012 · Parkinsonism & Related Disorders
  28. Revisiting the advance of age-dependent α-synuclein propagation and aggregation
    Dong‐Yan Song, Jiayi Li · 2025 · Ageing and Neurodegenerative Diseases
  29. Potent inhibitors of toxic alpha-synuclein oligomers identified via cellular time-resolved FRET biosensor
    Anthony R. Braun, Elly E. Liao, Mian Horvath, Malaney C. Young, Chih Hung Lo, Roland Z. Brown, Michael D. Evans, Kelvin C. Luk, David Dale Thomas, Jonathan N. Sachs · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  30. OMA1 protease eliminates arrested protein import intermediates upon depolarization of the inner mitochondrial membrane
    Magda Krakowczyk, Anna M. Lenkiewicz, Tomasz Sitarz, Ben Hur Marins Mussulini, Vanessa Linke, Dominika Malińska, Andrzej Antoni Szczepankiewicz, Agata Wydrych, Hanna Nieznańska, Remigiusz Adam Serwa et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Serum Apo Lipoprotein E, Apo Lipoprotein E Gene Polymorphisms, and Parkinson’s Disease
    Ebtesam Mohamed Fahmy, Amany Mahmoud Rabah, Saher El-Sayed Hashem, Laila Ahmed Rashed, Heba A. Deraz, Rania Shehata Ismail · 2024 · Neurology India
  32. APOE genetic variability in an Egyptian cohort of PD
    Eman Mohamed Khedr, Martina B. William, Aliaa A Elhosseiny, Ali Shalash, Gharib Fawi, Mohamed H. Yousef, Shaimaa Ibrahim El-Jaafary, Hamin Lee, Alina Jama, Mohamed Koraym et al. · 2025 · Frontiers in Neuroscience
  33. Deciphering the Janus‐Faced Nature of the Apolipoprotein Superfamily in Parkinsonian Neurodegeneration: Molecular Crosstalk Between the Astroglial Secretome and Neuronal Homeostasis
    Yingying Dai, Mingxia Bi, Qian Jiao, Xixun Du, Xi Chen, Chunling Yan, Hong Fu Jiang · 2025 · Movement Disorders
  34. Elucidating the role of APOE ε4 gene variants in the clinical manifestation of Parkinson's disease
    Gita Vita Soraya, Yusran Ady Fitrah, Andi Kurnia Bintang, Muhammad Akbar, Alfi Raudatil Jannah, Zulvikar Syambani Ulhaq, Jumraini Tammasse, Cahyono Kaelan, Muhammad Nasrum Massi, Ai Obinata et al. · 2025 · Frontiers in Aging Neuroscience
  35. Modeling synucleinopathies in genetically modified animals: Successes and failures
    Natalia N. Ninkina, A. A. Ustyugov, Vladimir L. Buchman · 2008 · Molecular Biology
  36. General aspects
    Dag Aarsland, Jeffrey L. Cummings, Daniel Weintraub, К. Ray Chaudhuri · 2013 · Cambridge University Press eBooks
  37. Regional lysosomal malfunction underlies the selectivity of alpha-synuclein neurodegeneration
    Kristen A. Malkus · 2011 · Scholarly Commons (University of Pennsylvania)
  38. The endogenous repair capacity of the parkinsonian brain
    Simone A. van den Berge · 2011
  39. The genetics of behavior and cognition in Parkinson’s disease
    Caroline H. Williams‐Gray, Roger A. Barker · 2013 · Cambridge University Press eBooks
  40. Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects
    Kyoungjune Pak, Seunghyeon Shin, So Jung Kim, Keunyoung Kim, Bum‐Soo Kim, Seong‐Jang Kim, In Joo Kim · 2017 · Scientific Reports
  41. Influences of the Global Deterioration Scale according to Routine Blood Chemistry Results
    Sun-Gyu Kim, Chang-Eun Park · 2019 · Korean Journal of Clinical Laboratory Science
  42. Additional file 1 of Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
    Grace M. Lloyd, Long, Brooke, Stephan S. Quintin, Zachary A. Sorrentino, Gorion, Kimberly-Marie M., Brach M. Bell, Denise Carrillo, Patrick M. Sullivan, David B. Borchelt, Benoit I. Giasson · 2024 · Figshare
  43. Additional file 1 of RGS5 augments astrocyte activation and facilitates neuroinflammation via TNF signaling
    Shu Yin, Ma, Xin-yue, Sun, Ying-feng, Yin, Yan-qing, Long, Ying, Zhao, Chun-lai, Ma, Jun-wei, Li, Sen, Hu, Yan, Li, Ming-tao et al. · 2023 · Figshare
  44. Challenges in Studying Synapses in Alzheimer's Disease
    Thomas Christian Südhof · 2026 · Annals of Neurology
  45. Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?
    Silas A. Buck, Sidharth S. Madhavan, Laurie H. Sanders · 2026 · Molecular Neurodegeneration Advances